Ramiven 100mg Tablet

About

Ramiven 100mg Tablet contains Rivaroxaban, a direct oral anticoagulant (DOAC) that functions as a highly selective inhibitor of Factor Xa. Factor Xa is a pivotal enzyme in the intrinsic and extrinsic coagulation pathways, playing a central role in the conversion of prothrombin to thrombin. Thrombin, in turn, is essential for the conversion of fibrinogen to fibrin, which forms the structural meshwork of a blood clot. By directly inhibiting Factor Xa, Rivaroxaban effectively disrupts the coagulation cascade, leading to a significant reduction in thrombin generation and subsequent clot formation. This mechanism makes it highly effective in both preventing and treating various thromboembolic conditions, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in patients with non-valvular atrial fibrillation. Its predictable pharmacokinetics and pharmacodynamics allow for fixed-dose regimens without the need for routine coagulation monitoring, enhancing patient convenience and adherence.

Uses

• Prevention of stroke and systemic embolism in non-valvular atrial fibrillation.
• Treatment of deep vein thrombosis (DVT).
• Treatment of pulmonary embolism (PE).
• Prevention of recurrent DVT and PE.

Directions For Use

Take this tablet orally with food, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Effective in preventing blood clots.
• Reduces risk of stroke in AFib.
• Treats and prevents DVT/PE.
• Oral administration, no injections.
• Fixed dosing, no routine monitoring.
• Rapid onset of action.

Side Effects

• Bleeding (e.g., nosebleeds, gum bleeding)
• Bruising
• Nausea
• Abdominal pain
• Dyspepsia
• Fatigue
• Dizziness
• Headache
• Peripheral edema
• Increased liver enzymes
• Rash
• Anemia

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can increase the risk of bleeding.
• Pregnancy - Contraindicated during pregnancy due to the risk of hemorrhage in the mother and fetus.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and cause bleeding in the infant.
• Liver - Contraindicated in patients with liver disease associated with coagulopathy and clinically relevant bleeding risk.
• Kidney - Use with caution in patients with severe kidney impairment; dose adjustment may be necessary or contraindicated.
• Lung - No specific contraindications related to lung conditions, but caution with active lung bleeding.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.